Thank you for visiting Gilead.com. Please explore this section for the latest news about Gilead, our groundbreaking research and our therapeutics.
Please see Gilead-at-a-Glance to learn more about the company and our portfolio of products.
Sign-up to receive email alerts whenever new company information is posted to the site.
Recent NewsMay 7, 2008 Gilead Appoints John C. Martin as Chairman of Board of Directors; Names John F. Milligan President
May 1, 2008 Gilead Initiates Letairis(R) (ambrisentan) Phase IV Program
April 25, 2008 European Commission Approves Viread(R) for Chronic Hepatitis B
April 24, 2008 Gilead Sciences to Present at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30
April 24, 2008 Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B
April 21, 2008 Robin L. Washington to Join Gilead as Senior Vice President and Chief Financial Officer
April 16, 2008 Gilead Sciences Announces First Quarter 2008 Financial Results
April 9, 2008 Gilead Sciences to Release First Quarter 2008 Financial Results on Wednesday, April 16, 2008
|